Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab informa… Read more
Rapid Micro Biosystems Inc (RPID) - Total Assets
Latest total assets as of September 2025: $84.41 Million USD
Based on the latest financial reports, Rapid Micro Biosystems Inc (RPID) holds total assets worth $84.41 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Rapid Micro Biosystems Inc - Total Assets Trend (2010–2024)
This chart illustrates how Rapid Micro Biosystems Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Rapid Micro Biosystems Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Rapid Micro Biosystems Inc's total assets of $84.41 Million consist of 82.4% current assets and 17.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.2% |
| Accounts Receivable | $7.53 Million | 7.7% |
| Inventory | $20.20 Million | 20.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2010–2024)
This chart illustrates how Rapid Micro Biosystems Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rapid Micro Biosystems Inc's current assets represent 82.4% of total assets in 2024, an increase from 0.0% in 2010.
- Cash Position: Cash and equivalents constituted 17.2% of total assets in 2024, up from 6.7% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 49.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 20.6% of total assets.
Rapid Micro Biosystems Inc Competitors by Total Assets
Key competitors of Rapid Micro Biosystems Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Rapid Micro Biosystems Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Rapid Micro Biosystems Inc generates 0.29x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Rapid Micro Biosystems Inc is currently not profitable relative to its asset base.
Rapid Micro Biosystems Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.23 | 5.52 | 4.00 |
| Quick Ratio | 2.95 | 4.19 | 3.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $53.40 Million | $ 72.01 Million | $ 46.60 Million |
Rapid Micro Biosystems Inc - Advanced Valuation Insights
This section examines the relationship between Rapid Micro Biosystems Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.91 |
| Latest Market Cap to Assets Ratio | 0.56 |
| Asset Growth Rate (YoY) | -31.6% |
| Total Assets | $98.17 Million |
| Market Capitalization | $55.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values Rapid Micro Biosystems Inc's assets below their book value (0.56 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Rapid Micro Biosystems Inc's assets decreased by 31.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Rapid Micro Biosystems Inc (2010–2024)
The table below shows the annual total assets of Rapid Micro Biosystems Inc from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $98.17 Million | -31.57% |
| 2023-12-31 | $143.45 Million | -24.76% |
| 2022-12-31 | $190.65 Million | -20.95% |
| 2021-12-31 | $241.17 Million | +244.54% |
| 2020-12-31 | $70.00 Million | +120.89% |
| 2019-12-31 | $31.69 Million | +1805.47% |
| 2011-12-31 | $1.66 Million | -28.29% |
| 2010-12-31 | $2.32 Million | -- |